APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lornoxicam Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lornoxicam Tablets Market Analysis and Forecast 2026-2032

Report ID 174009030229 December 2025194 pages

Choose your research edition.

Industry ResearchLornoxicam Tablets Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Lornoxicam Tablets Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Lornoxicam Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lornoxicam Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Lornoxicam Tablets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Lornoxicam Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lornoxicam Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lornoxicam Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lornoxicam Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lornoxicam Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lornoxicam Tablets include Glenmark, Lupin Limited, Takeda Pharmaceuticals, Shandong Jincheng Pharmaceutical and Zhejiang Zhenyuan Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lornoxicam Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lornoxicam Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Lornoxicam Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lornoxicam Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lornoxicam Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lornoxicam Tablets sales, projected growth trends, production technology, application and end-user industry.

Lornoxicam Tablets Segment by Company

Glenmark

Lupin Limited

Takeda Pharmaceuticals

Shandong Jincheng Pharmaceutical

Zhejiang Zhenyuan Pharmaceutical

Lornoxicam Tablets Segment by Type

4mg

8mg

Lornoxicam Tablets Segment by Application

Hospital and Clinic

Pharmacy

Lornoxicam Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lornoxicam Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lornoxicam Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lornoxicam Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lornoxicam Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lornoxicam Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lornoxicam Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lornoxicam Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 4mg Major Manufacturers Table 3. 8mg Major Manufacturers Table 4. Global Lornoxicam Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Lornoxicam Tablets Industry Trends Table 8. Lornoxicam Tablets Industry Drivers Table 9. Lornoxicam Tablets Industry Opportunities and Challenges Table 10. Lornoxicam Tablets Industry Restraints Table 11. Global Lornoxicam Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Lornoxicam Tablets Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Lornoxicam Tablets Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Lornoxicam Tablets Revenue Market Share by Region (2021-2026) Table 15. Global Lornoxicam Tablets Revenue Market Share by Region (2027-2032) Table 16. Global Lornoxicam Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Lornoxicam Tablets Sales by Region (2021-2026) & (K Units) Table 18. Global Lornoxicam Tablets Sales by Region (2027-2032) & (K Units) Table 19. Global Lornoxicam Tablets Sales Market Share by Region (2021-2026) Table 20. Global Lornoxicam Tablets Sales Market Share by Region (2027-2032) Table 21. Global Lornoxicam Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Lornoxicam Tablets Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Lornoxicam Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Lornoxicam Tablets Sales Market Share by Manufacturers (2021-2026) Table 25. Global Lornoxicam Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Lornoxicam Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Lornoxicam Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Lornoxicam Tablets Manufacturers, Product Type & Application Table 29. Global Lornoxicam Tablets Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Lornoxicam Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Lornoxicam Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Lornoxicam Tablets Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Lornoxicam Tablets Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Lornoxicam Tablets Revenue Market Share by Type (2021-2026) Table 36. Global Lornoxicam Tablets Revenue Market Share by Type (2027-2032) Table 37. Global Lornoxicam Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Lornoxicam Tablets Sales by Type (2021-2026) & (K Units) Table 39. Global Lornoxicam Tablets Sales by Type (2027-2032) & (K Units) Table 40. Global Lornoxicam Tablets Sales Market Share by Type (2021-2026) Table 41. Global Lornoxicam Tablets Sales Market Share by Type (2027-2032) Table 42. Global Lornoxicam Tablets Price by Type (2021-2026) & (US$/Unit) Table 43. Global Lornoxicam Tablets Price by Type (2027-2032) & (US$/Unit) Table 44. Global Lornoxicam Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Lornoxicam Tablets Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Lornoxicam Tablets Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Lornoxicam Tablets Revenue Market Share by Application (2021-2026) Table 48. Global Lornoxicam Tablets Revenue Market Share by Application (2027-2032) Table 49. Global Lornoxicam Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Lornoxicam Tablets Sales by Application (2021-2026) & (K Units) Table 51. Global Lornoxicam Tablets Sales by Application (2027-2032) & (K Units) Table 52. Global Lornoxicam Tablets Sales Market Share by Application (2021-2026) Table 53. Global Lornoxicam Tablets Sales Market Share by Application (2027-2032) Table 54. Global Lornoxicam Tablets Price by Application (2021-2026) & (US$/Unit) Table 55. Global Lornoxicam Tablets Price by Application (2027-2032) & (US$/Unit) Table 56. Glenmark Company Information Table 57. Glenmark Business Overview Table 58. Glenmark Lornoxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Glenmark Lornoxicam Tablets Product Portfolio Table 60. Glenmark Recent Development Table 61. Lupin Limited Company Information Table 62. Lupin Limited Business Overview Table 63. Lupin Limited Lornoxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Lupin Limited Lornoxicam Tablets Product Portfolio Table 65. Lupin Limited Recent Development Table 66. Takeda Pharmaceuticals Company Information Table 67. Takeda Pharmaceuticals Business Overview Table 68. Takeda Pharmaceuticals Lornoxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Takeda Pharmaceuticals Lornoxicam Tablets Product Portfolio Table 70. Takeda Pharmaceuticals Recent Development Table 71. Shandong Jincheng Pharmaceutical Company Information Table 72. Shandong Jincheng Pharmaceutical Business Overview Table 73. Shandong Jincheng Pharmaceutical Lornoxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Shandong Jincheng Pharmaceutical Lornoxicam Tablets Product Portfolio Table 75. Shandong Jincheng Pharmaceutical Recent Development Table 76. Zhejiang Zhenyuan Pharmaceutical Company Information Table 77. Zhejiang Zhenyuan Pharmaceutical Business Overview Table 78. Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Product Portfolio Table 80. Zhejiang Zhenyuan Pharmaceutical Recent Development Table 81. North America Lornoxicam Tablets Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Lornoxicam Tablets Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Lornoxicam Tablets Sales by Type (2021-2026) & (K Units) Table 84. North America Lornoxicam Tablets Sales by Type (2027-2032) & (K Units) Table 85. North America Lornoxicam Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 86. North America Lornoxicam Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 87. North America Lornoxicam Tablets Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Lornoxicam Tablets Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Lornoxicam Tablets Sales by Application (2021-2026) & (K Units) Table 90. North America Lornoxicam Tablets Sales by Application (2027-2032) & (K Units) Table 91. North America Lornoxicam Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 92. North America Lornoxicam Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 93. North America Lornoxicam Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Lornoxicam Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Lornoxicam Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Lornoxicam Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 97. North America Lornoxicam Tablets Sales by Country (2021-2026) & (K Units) Table 98. North America Lornoxicam Tablets Sales by Country (2027-2032) & (K Units) Table 99. North America Lornoxicam Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 100. North America Lornoxicam Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 101. United States Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 102. Canada Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 103. Mexico Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 104. Europe Lornoxicam Tablets Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Lornoxicam Tablets Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Lornoxicam Tablets Sales by Type (2021-2026) & (K Units) Table 107. Europe Lornoxicam Tablets Sales by Type (2027-2032) & (K Units) Table 108. Europe Lornoxicam Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 109. Europe Lornoxicam Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 110. Europe Lornoxicam Tablets Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Lornoxicam Tablets Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Lornoxicam Tablets Sales by Application (2021-2026) & (K Units) Table 113. Europe Lornoxicam Tablets Sales by Application (2027-2032) & (K Units) Table 114. Europe Lornoxicam Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 115. Europe Lornoxicam Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 116. Europe Lornoxicam Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Lornoxicam Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Lornoxicam Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Lornoxicam Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 120. Europe Lornoxicam Tablets Sales by Country (2021-2026) & (K Units) Table 121. Europe Lornoxicam Tablets Sales by Country (2027-2032) & (K Units) Table 122. Europe Lornoxicam Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 123. Europe Lornoxicam Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 124. Germany Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 125. France Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 126. U.K. Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 127. Italy Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 128. Russia Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 129. Spain Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 132. Sweden Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 133. Poland Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 134. China Lornoxicam Tablets Revenue by Type (2021-2026) & (US$ Million) Table 135. China Lornoxicam Tablets Revenue by Type (2027-2032) & (US$ Million) Table 136. China Lornoxicam Tablets Sales by Type (2021-2026) & (K Units) Table 137. China Lornoxicam Tablets Sales by Type (2027-2032) & (K Units) Table 138. China Lornoxicam Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Lornoxicam Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Lornoxicam Tablets Revenue by Application (2021-2026) & (US$ Million) Table 141. China Lornoxicam Tablets Revenue by Application (2027-2032) & (US$ Million) Table 142. China Lornoxicam Tablets Sales by Application (2021-2026) & (K Units) Table 143. China Lornoxicam Tablets Sales by Application (2027-2032) & (K Units) Table 144. China Lornoxicam Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Lornoxicam Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Lornoxicam Tablets Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Lornoxicam Tablets Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Lornoxicam Tablets Sales by Type (2021-2026) & (K Units) Table 149. Asia Lornoxicam Tablets Sales by Type (2027-2032) & (K Units) Table 150. Asia Lornoxicam Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Lornoxicam Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Lornoxicam Tablets Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Lornoxicam Tablets Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Lornoxicam Tablets Sales by Application (2021-2026) & (K Units) Table 155. Asia Lornoxicam Tablets Sales by Application (2027-2032) & (K Units) Table 156. Asia Lornoxicam Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Lornoxicam Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Lornoxicam Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Lornoxicam Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Lornoxicam Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Lornoxicam Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Lornoxicam Tablets Sales by Country (2021-2026) & (K Units) Table 163. Asia Lornoxicam Tablets Sales by Country (2027-2032) & (K Units) Table 164. Asia Lornoxicam Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Lornoxicam Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 167. South Korea Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 168. India Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 169. Australia Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Lornoxicam Tablets Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Lornoxicam Tablets Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Lornoxicam Tablets Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Lornoxicam Tablets Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Lornoxicam Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Lornoxicam Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Lornoxicam Tablets Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Lornoxicam Tablets Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Lornoxicam Tablets Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Lornoxicam Tablets Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Lornoxicam Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Lornoxicam Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Lornoxicam Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Lornoxicam Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Lornoxicam Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Lornoxicam Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Lornoxicam Tablets Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Lornoxicam Tablets Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Lornoxicam Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Lornoxicam Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 193. Argentina Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 194. Chile Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 195. Colombia Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 196. Peru Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 198. Israel Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 199. UAE Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 200. Turkey Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 201. Iran Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 202. Egypt Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Lornoxicam Tablets Distributors List Table 206. Lornoxicam Tablets Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Lornoxicam Tablets Image Figure 2. Global Lornoxicam Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lornoxicam Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 4mg Image Figure 5. 8mg Image Figure 6. Global Lornoxicam Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Lornoxicam Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Pharmacy Image Figure 10. Global Lornoxicam Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Lornoxicam Tablets Revenue (2021-2032) & (US$ Million) Figure 12. Global Lornoxicam Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Lornoxicam Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Lornoxicam Tablets Revenue Market Share by Region (2021-2032) Figure 15. Global Lornoxicam Tablets Sales (2021-2032) & (K Units) Figure 16. Global Lornoxicam Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Lornoxicam Tablets Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Lornoxicam Tablets Sales YoY (2021-2032) & (K Units) Figure 19. Europe Lornoxicam Tablets Sales YoY (2021-2032) & (K Units) Figure 20. China Lornoxicam Tablets Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Lornoxicam Tablets Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Lornoxicam Tablets Sales YoY (2021-2032) & (K Units) Figure 23. Global Lornoxicam Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Lornoxicam Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Lornoxicam Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Lornoxicam Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Lornoxicam Tablets Revenue Market Share by Type (2021-2032) Figure 29. Global Lornoxicam Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Lornoxicam Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Lornoxicam Tablets Sales Market Share by Type (2021-2032) Figure 32. Global Lornoxicam Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Lornoxicam Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Lornoxicam Tablets Revenue Market Share by Application (2021-2032) Figure 35. Global Lornoxicam Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Lornoxicam Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Lornoxicam Tablets Sales Market Share by Application (2021-2032) Figure 38. North America Lornoxicam Tablets Revenue Share by Type (2021-2032) Figure 39. North America Lornoxicam Tablets Sales Share by Type (2021-2032) Figure 40. North America Lornoxicam Tablets Revenue Share by Application (2021-2032) Figure 41. North America Lornoxicam Tablets Sales Share by Application (2021-2032) Figure 42. North America Lornoxicam Tablets Revenue Share by Country (2021-2032) Figure 43. North America Lornoxicam Tablets Sales Share by Country (2021-2032) Figure 44. Europe Lornoxicam Tablets Revenue Share by Type (2021-2032) Figure 45. Europe Lornoxicam Tablets Sales Share by Type (2021-2032) Figure 46. Europe Lornoxicam Tablets Revenue Share by Application (2021-2032) Figure 47. Europe Lornoxicam Tablets Sales Share by Application (2021-2032) Figure 48. Europe Lornoxicam Tablets Revenue Share by Country (2021-2032) Figure 49. Europe Lornoxicam Tablets Sales Share by Country (2021-2032) Figure 50. China Lornoxicam Tablets Revenue Share by Type (2021-2032) Figure 51. China Lornoxicam Tablets Sales Share by Type (2021-2032) Figure 52. China Lornoxicam Tablets Revenue Share by Application (2021-2032) Figure 53. China Lornoxicam Tablets Sales Share by Application (2021-2032) Figure 54. Asia Lornoxicam Tablets Revenue Share by Type (2021-2032) Figure 55. Asia Lornoxicam Tablets Sales Share by Type (2021-2032) Figure 56. Asia Lornoxicam Tablets Revenue Share by Application (2021-2032) Figure 57. Asia Lornoxicam Tablets Sales Share by Application (2021-2032) Figure 58. Asia Lornoxicam Tablets Revenue Share by Country (2021-2032) Figure 59. Asia Lornoxicam Tablets Sales Share by Country (2021-2032) Figure 60. SAMEA Lornoxicam Tablets Revenue Share by Type (2021-2032) Figure 61. SAMEA Lornoxicam Tablets Sales Share by Type (2021-2032) Figure 62. SAMEA Lornoxicam Tablets Revenue Share by Application (2021-2032) Figure 63. SAMEA Lornoxicam Tablets Sales Share by Application (2021-2032) Figure 64. SAMEA Lornoxicam Tablets Revenue Share by Country (2021-2032) Figure 65. SAMEA Lornoxicam Tablets Sales Share by Country (2021-2032) Figure 66. Lornoxicam Tablets Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Lornoxicam Tablets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 4mg
  • 8mg
Applications
  • Hospital and Clinic
  • Pharmacy
Companies covered
  • Glenmark
  • Lupin Limited
  • Takeda Pharmaceuticals
  • Shandong Jincheng Pharmaceutical
  • Zhejiang Zhenyuan Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lornoxicam Tablets Market by Type
  3. 1.2.1 Global Lornoxicam Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 4mg
  5. 1.2.3 8mg
  6. 1.3 Lornoxicam Tablets Market by Application
  7. 1.3.1 Global Lornoxicam Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Pharmacy
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Lornoxicam Tablets Market Dynamics
  1. 2.1 Lornoxicam Tablets Industry Trends
  2. 2.2 Lornoxicam Tablets Industry Drivers
  3. 2.3 Lornoxicam Tablets Industry Opportunities and Challenges
  4. 2.4 Lornoxicam Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lornoxicam Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lornoxicam Tablets Revenue by Region
  3. 3.2.1 Global Lornoxicam Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lornoxicam Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Lornoxicam Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Lornoxicam Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lornoxicam Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lornoxicam Tablets Sales by Region
  9. 3.4.1 Global Lornoxicam Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lornoxicam Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Lornoxicam Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Lornoxicam Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lornoxicam Tablets Revenue by Manufacturers
  2. 4.1.1 Global Lornoxicam Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lornoxicam Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lornoxicam Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lornoxicam Tablets Sales by Manufacturers
  6. 4.2.1 Global Lornoxicam Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lornoxicam Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lornoxicam Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lornoxicam Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lornoxicam Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lornoxicam Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lornoxicam Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Lornoxicam Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lornoxicam Tablets Market CR5 and HHI
  16. 4.8.2 2025 Lornoxicam Tablets Tier 1, Tier 2, and Tier 3
5 Lornoxicam Tablets Market by Type
  1. 5.1 Global Lornoxicam Tablets Revenue by Type
  2. 5.1.1 Global Lornoxicam Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lornoxicam Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lornoxicam Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lornoxicam Tablets Sales by Type
  6. 5.2.1 Global Lornoxicam Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lornoxicam Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Lornoxicam Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lornoxicam Tablets Price by Type
6 Lornoxicam Tablets Market by Application
  1. 6.1 Global Lornoxicam Tablets Revenue by Application
  2. 6.1.1 Global Lornoxicam Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lornoxicam Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lornoxicam Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lornoxicam Tablets Sales by Application
  6. 6.2.1 Global Lornoxicam Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lornoxicam Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Lornoxicam Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lornoxicam Tablets Price by Application
7 Company Profiles
  1. 7.1 Glenmark
  2. 7.1.1 Glenmark Company Information
  3. 7.1.2 Glenmark Business Overview
  4. 7.1.3 Glenmark Lornoxicam Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Glenmark Lornoxicam Tablets Product Portfolio
  6. 7.1.5 Glenmark Recent Developments
  7. 7.2 Lupin Limited
  8. 7.2.1 Lupin Limited Company Information
  9. 7.2.2 Lupin Limited Business Overview
  10. 7.2.3 Lupin Limited Lornoxicam Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Lupin Limited Lornoxicam Tablets Product Portfolio
  12. 7.2.5 Lupin Limited Recent Developments
  13. 7.3 Takeda Pharmaceuticals
  14. 7.3.1 Takeda Pharmaceuticals Company Information
  15. 7.3.2 Takeda Pharmaceuticals Business Overview
  16. 7.3.3 Takeda Pharmaceuticals Lornoxicam Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Takeda Pharmaceuticals Lornoxicam Tablets Product Portfolio
  18. 7.3.5 Takeda Pharmaceuticals Recent Developments
  19. 7.4 Shandong Jincheng Pharmaceutical
  20. 7.4.1 Shandong Jincheng Pharmaceutical Company Information
  21. 7.4.2 Shandong Jincheng Pharmaceutical Business Overview
  22. 7.4.3 Shandong Jincheng Pharmaceutical Lornoxicam Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shandong Jincheng Pharmaceutical Lornoxicam Tablets Product Portfolio
  24. 7.4.5 Shandong Jincheng Pharmaceutical Recent Developments
  25. 7.5 Zhejiang Zhenyuan Pharmaceutical
  26. 7.5.1 Zhejiang Zhenyuan Pharmaceutical Company Information
  27. 7.5.2 Zhejiang Zhenyuan Pharmaceutical Business Overview
  28. 7.5.3 Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Product Portfolio
  30. 7.5.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Lornoxicam Tablets Market Size by Type
  2. 8.1.1 North America Lornoxicam Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Lornoxicam Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Lornoxicam Tablets Price by Type (2021-2032)
  5. 8.2 North America Lornoxicam Tablets Market Size by Application
  6. 8.2.1 North America Lornoxicam Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Lornoxicam Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Lornoxicam Tablets Price by Application (2021-2032)
  9. 8.3 North America Lornoxicam Tablets Market Size by Country
  10. 8.3.1 North America Lornoxicam Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lornoxicam Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lornoxicam Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Lornoxicam Tablets Market Size by Type
  2. 9.1.1 Europe Lornoxicam Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lornoxicam Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Lornoxicam Tablets Price by Type (2021-2032)
  5. 9.2 Europe Lornoxicam Tablets Market Size by Application
  6. 9.2.1 Europe Lornoxicam Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lornoxicam Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Lornoxicam Tablets Price by Application (2021-2032)
  9. 9.3 Europe Lornoxicam Tablets Market Size by Country
  10. 9.3.1 Europe Lornoxicam Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lornoxicam Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lornoxicam Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Lornoxicam Tablets Market Size by Type
  2. 10.1.1 China Lornoxicam Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Lornoxicam Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Lornoxicam Tablets Price by Type (2021-2032)
  5. 10.2 China Lornoxicam Tablets Market Size by Application
  6. 10.2.1 China Lornoxicam Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Lornoxicam Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Lornoxicam Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lornoxicam Tablets Market Size by Type
  2. 11.1.1 Asia Lornoxicam Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lornoxicam Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Lornoxicam Tablets Price by Type (2021-2032)
  5. 11.2 Asia Lornoxicam Tablets Market Size by Application
  6. 11.2.1 Asia Lornoxicam Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lornoxicam Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Lornoxicam Tablets Price by Application (2021-2032)
  9. 11.3 Asia Lornoxicam Tablets Market Size by Country
  10. 11.3.1 Asia Lornoxicam Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lornoxicam Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lornoxicam Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lornoxicam Tablets Market Size by Type
  2. 12.1.1 SAMEA Lornoxicam Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lornoxicam Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lornoxicam Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Lornoxicam Tablets Market Size by Application
  6. 12.2.1 SAMEA Lornoxicam Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lornoxicam Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lornoxicam Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Lornoxicam Tablets Market Size by Country
  10. 12.3.1 SAMEA Lornoxicam Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lornoxicam Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lornoxicam Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lornoxicam Tablets Value Chain Analysis
  2. 13.1.1 Lornoxicam Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lornoxicam Tablets Production Mode & Process
  6. 13.2 Lornoxicam Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lornoxicam Tablets Distributors
  9. 13.2.3 Lornoxicam Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst